Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency
- PMID: 1037222
Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency
Abstract
The effect of ethyl apovincaminate (RGH-4405, Cavinton) on the rheoencephalogram and memory functions was studied in 50 patients with ischaemic disturbances of cerebral circulation. The drug was administered in a single i.v. dose of 10 mg and orally three times daily 5 mg for a month. Improvement of cerebral circulation was observed after i.v. and oral medication. Blood flow was most markedly increased in the gray matter. The effect on arterial pressure was negligible. Improvement of memorizing capacity evaluated by psychological tests was recorded after one month of Cavinton treatment, associated with alleviation or complete disappearance of symptoms. No side-effects attributable to the drug were observed. It is pointed out that Cavinton is indicated in the treatment of ischaemic disorders of the cerebral circulation, particularly in chronic insufficiency.
Similar articles
-
Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease.Arzneimittelforschung. 1976;26(10a):1945-7. Arzneimittelforschung. 1976. PMID: 1037221
-
Ethyl apovincaminate therapy in neurovascular diseases.Arzneimittelforschung. 1976;26(10a):1984-9. Arzneimittelforschung. 1976. PMID: 1037230
-
Radiocirculographic study of the effect of ethyl apovincaminate on the cerebral circulation.Arzneimittelforschung. 1976;26(10a):1963-4. Arzneimittelforschung. 1976. PMID: 798589
-
[The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].Orv Hetil. 2001 Feb 25;142(8):383-9. Orv Hetil. 2001. PMID: 11263076 Review. Hungarian.
-
[Treatment of patients with initial manifestations of cerebral circulation insufficiency in vasomotor dystonias].Klin Med (Mosk). 1992 May-Jun;70(5-6):56-60. Klin Med (Mosk). 1992. PMID: 1434406 Review. Russian. No abstract available.
Cited by
-
Psychopharmacological effects of vinpocetine in normal healthy volunteers.Eur J Clin Pharmacol. 1985;28(5):567-71. doi: 10.1007/BF00544068. Eur J Clin Pharmacol. 1985. PMID: 3899677 Clinical Trial.
-
Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.Eur J Clin Pharmacol. 1987;33(2):185-9. doi: 10.1007/BF00544565. Eur J Clin Pharmacol. 1987. PMID: 3691609
-
Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.Eur J Drug Metab Pharmacokinet. 1990 Jan-Mar;15(1):1-5. doi: 10.1007/BF03190120. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2384112